60 Degrees Pharmaceuticals Inc (SXTP) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket
 
60 Degrees Pharmaceuticals Inc   (NASDAQ: SXTP)

Select the Financial Report: Select the Period:


Description of 60 Degrees Pharmaceuticals Inc's Business Segments


60 Degrees Pharmaceuticals Inc. is a healthcare firm focused on developing and commercializing innovative therapies to address unmet medical needs. The company primarily operates in the pharmaceutical and biopharmaceutical sectors and is known for its specialization in tropical and infectious diseases, particularly those affecting populations in both developed and developing countries.

Segments

1. Pharmaceutical Development
- 60 Degrees Pharmaceuticals engages in the research and development of pharmaceutical products aimed at treating infectious diseases. This segment focuses on both novel drug formulations and repurposing existing medications for new indications.

2. Clinical Trials
- The company conducts extensive clinical trials to evaluate the safety and efficacy of its products. This segment involves collaboration with healthcare institutions and researchers to collect and analyze data that informs regulatory submissions.

3. Regulatory Affairs
- 60 Degrees Pharmaceuticals has a dedicated team for navigating the complexities of regulatory frameworks across different regions. This segment plays a crucial role in ensuring all products meet the necessary guidelines set by authorities such as the FDA (U.S. Food and Drug Administration) and EMA (European Medicines Agency).

4. Market Access and Commercialization
- This segment involves strategic planning for the commercialization of products once they receive regulatory approval. It includes market analysis, pricing strategies, and partnership development with distributors and healthcare organizations.

5. Global Health Initiatives
- 60 Degrees Pharmaceuticals actively engages in global health initiatives focusing on diseases that are prevalent in resource-limited settings. This segment emphasizes partnerships with non-governmental organizations (NGOs), governments, and international health bodies.

Products

1. Antimicrobial Agents
- The company has developed a range of antimicrobial agents that target various bacterial and viral infections. These products include both traditional antibiotics and novel compounds that address antibiotic resistance.

2. Vaccines
- 60 Degrees Pharmaceuticals is involved in the development of vaccines for infectious diseases, particularly those that pose significant health risks in tropical climates. This includes both preventive vaccines and therapeutic vaccines aimed at treating existing infections.

3. Infectious Disease Therapies
- The company specializes in creating therapies specifically designed to treat diseases such as malaria, TB, and neglected tropical diseases. These therapies might include single-agent drugs or combination therapies that enhance treatment outcomes.

4. Diagnostic Tools
- Alongside therapeutic products, the company develops diagnostic tools that help in the early detection and management of infectious diseases. These tools may involve rapid test kits or molecular diagnostics that facilitate timely treatment.

5. Combination Products
- 60 Degrees Pharmaceuticals is also exploring the development of combination products that integrate drugs with diagnostic or therapeutic devices, aiming to provide comprehensive solutions for disease management.

Services

1. Consultative Services
- The company offers consultative services to healthcare providers and organizations looking for expertise in infectious disease management. This may encompass treatment protocol development, education, and training on product usage and adherence.

2. Collaborative Research Agreements
- 60 Degrees Pharmaceuticals enters into collaborative agreements with academic institutions and research organizations to advance the science of infectious disease treatment and expand the pipeline of potential therapies.

3. Supply Chain Management
- The company manages complex supply chains to ensure the distribution of its products reaches areas of need, especially in challenging logistical environments typical in emerging markets.

4. Post-Marketing Surveillance
- Once products are on the market, 60 Degrees Pharmaceuticals conducts post-marketing surveillance to monitor the effectiveness and safety of its therapies in real-world settings.

In closing, 60 Degrees Pharmaceuticals Inc. stands out for its commitment to improving global health through innovative pharmaceutical solutions tailored to combat infectious diseases. Its extensive range of segments, products, and services showcases a holistic approach to addressing pressing health challenges, particularly in underserved regions.


(Jun 30 2026) three months ended Q2
Business Segments Revenues
(in millions $)
Income
(in millions $)
%
(Profit Margin)
Total 0.21 -2.27 -

(Jun 30 2026) three months ended Q2
Revenue Growth rates by Segment Y/Y Revenue
%
Q/Q Revenue
%
Total 106.04 % 28.26 %

(Jun 30 2026) three months ended Q2
Income Growth rates by Segment Y/Y Income
%
Q/Q Income
%
Total - -


Annual Report on 60 Degrees Pharmaceuticals Inc Divisions, Sales by Country

 


Twelve months ended 2025
SXTP s Annual Revenue by Geography and Business Segments Sales
(in millions $)
%
(of total Sales)
Total 1.01 100 %


Twelve months ended 2025
SXTP s Annual Income by Country and Business Segments Income
(in millions $)
%
(Profit Margin)
Total -7.37 -

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.